cultivate(MD) - cultivate(MD)

Shoulder Innovations Reports Second Quarter 2025 Financial Results

Press Release / September 9, 2025

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line […]

Shoulder Innovations Reports Second Quarter 2025 Financial Results Read More »

Shoulder Innovations Stock Debuts on NYSE Under Ticker “SI”

News / July 31, 2025

We’re proud to share that Shoulder Innovations, Inc., a cultivate(MD) portfolio company and leader in shoulder surgical technology, has announced the pricing of its initial public offering of 5,000,000 shares of common stock at $15.00 per share. Shoulder Innovations is now publicly listed on the New York Stock Exchange under the ticker symbol “SI.” This

Shoulder Innovations Stock Debuts on NYSE Under Ticker “SI” Read More »

Nanochon Announces Health Canada Approval for First in Human Investigation

Press Release / July 11, 2025

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with

Nanochon Announces Health Canada Approval for First in Human Investigation Read More »

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer

Press Release / June 24, 2025

RAND RAPIDS, MI – June 24, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry,

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer Read More »

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort

News / June 11, 2025

We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants. This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology. MedTech Innovator

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort Read More »

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum

Press Release / June 11, 2025

Grand Rapids, MI – June 11, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company, Sterile Processing Express (SPDx), by Instrumentum, LLC, a fast-growing leader in surgical instrument sterilization services. This strategic acquisition expands Instrumentum’s operational footprint to five facilities across four states, significantly enhancing its capacity

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum Read More »

Author name: cultivate(MD)